1	9 have concomitant use of vigabatrin participant who take vigabatrin in the past must be off vigabatrin for approximately 5 month prior to visit 1 and must have documentation show no evidence of a vigabatrin-associated clinically significant abnormality in the visual perimetry test|vigabatrin[26,36]|||||||5 month[122,129]||C0048044|14851|14851|vigabatrin
1	9 have concomitant use of vigabatrin participant who take vigabatrin in the past must be off vigabatrin for approximately 5 month prior to visit 1 and must have documentation show no evidence of a vigabatrin-associated clinically significant abnormality in the visual perimetry test|vigabatrin[58,68]|||||||||C0048044|14851|14851|vigabatrin
1	9 have concomitant use of vigabatrin participant who take vigabatrin in the past must be off vigabatrin for approximately 5 month prior to visit 1 and must have documentation show no evidence of a vigabatrin-associated clinically significant abnormality in the visual perimetry test|vigabatrin[93,103]|||||||||C0048044|14851|14851|vigabatrin
1	9 have concomitant use of vigabatrin participant who take vigabatrin in the past must be off vigabatrin for approximately 5 month prior to visit 1 and must have documentation show no evidence of a vigabatrin-associated clinically significant abnormality in the visual perimetry test|vigabatrin[197,207]|||||||||C0048044|14851|14851|vigabatrin
